Pain
📧 Sign up to get email alerts when something new happens for Pain.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-12-19Clinical Trial Update: Enhancing Medication-based Analgesia in Humans- STUDY 2 [Phase 2]
Phase 2 clinical trial update on enhancing analgesia using medication-based approaches in humans; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-19Clinical Trial Update: Communication and Activation in Pain to Enhance Relationships and Treat Pain With Equity [NA]
A completed clinical trial focused on pain management and equitable relationships, with results posted in December 2023.
-
FDA approval · 2023-12-18FDA Approved: HYDROCODONE BITARTRATE AND IBUPROFEN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for HYDROCODONE BITARTRATE AND IBUPROFEN (Amneal Pharmaceuticals of New York LLC), authorizing its m…
-
FDA approval · 2023-12-15FDA Approved: DISKETS — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for DISKETS (methadone hydrochloride) from Hikma Pharmaceuticals USA Inc., indicating an approve…
-
FDA label_change · 2023-12-15FDA Approved: NALBUPHINE HYDROCHLORIDE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for nalbuphine hydrochloride by Hospira, updating labeling for this generic analgesic.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-12-15FDA Approved: METHADOSE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for Methadose (methadone hydrochloride) submitted by SpecGx LLC.
-
FDA approval · 2023-12-15FDA Approved: MEPERIDINE HYDROCHLORIDE — Supplemental Application (Genus Lifesciences Inc.)
The FDA approved Genus Lifesciences Inc.'s supplemental application for Meperidine Hydrochloride (ANDA 040893), a generic opioid analgesic. …
-
FDA approval · 2023-12-15FDA Approved: BUPRENORPHINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma)
FDA approved a supplemental application for buprenorphine hydrochloride (ANDA 090622) from PAI Holdings/PAI Pharma, confirming the approval …
-
FDA approval · 2023-12-15FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Genus Lifesciences Inc.)
FDA approved a supplemental application for Genus Lifesciences Inc.'s generic hydrocodone bitartrate and acetaminophen product. The action c…
-
FDA approval · 2023-12-15FDA Approved: TRAMADOL HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for tramadol hydrochloride, granting approval of a generic tramadol hydrochlori…
-
FDA approval · 2023-12-15FDA Approved: TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN — Supplemental Application (Micro Labs Limited)
The FDA approved a supplemental ANDA for Micro Labs Limited to market a tramadol hydrochloride and acetaminophen combination as a generic an…
-
FDA approval · 2023-12-15FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Mylan Institutional LLC)
The FDA approved a supplemental application for methadone hydrochloride submitted by Mylan Institutional LLC, updating regulatory status for…
-
FDA approval · 2023-12-15FDA Approved: BUPRENORPHINE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for buprenorphine from Actavis Pharma, Inc. The action indicates an additional approval under an…
-
FDA approval · 2023-12-15FDA Approved: TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for tramadol hydrochloride and acetaminophen from Aurobindo Pharma Limited.
-
FDA approval · 2023-12-15FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (KVK-Tech, Inc.)
FDA approved a supplemental application for Hydrocodone Bitartrate and Acetaminophen manufactured by KVK-Tech, Inc., approving the changes d…
-
FDA approval · 2023-12-15FDA Approved: OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN — Supplemental Application (Elite Laboratories, Inc.)
The FDA approved a supplemental application for Elite Laboratories, Inc.'s generic oxycodone hydrochloride and acetaminophen tablet, confirm…
-
FDA approval · 2023-12-15FDA Approved: DSUVIA — Supplemental Application (AcelRx Pharmaceuticals, Inc.)
FDA approved a supplemental application for DSUVIA (sufentanil) by AcelRx Pharmaceuticals, Inc., pertaining to this analgesic product.
-
FDA approval · 2023-12-15FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Camber Pharmaceuticals, Inc)
FDA approved a supplemental application for methadone hydrochloride from Camber Pharmaceuticals, Inc. This action grants continued approval …
-
FDA approval · 2023-12-15FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for methadone hydrochloride manufactured by Hikma Pharmaceuticals USA Inc., updating the approved pr…
-
FDA approval · 2023-12-15FDA Approved: OLINVYK — Supplemental Application (Trevena, Inc.)
The FDA approved a supplemental application for OLINVYK (oliceridine) from Trevena, Inc., to update the labeling as part of a supplemental a…
-
FDA approval · 2023-12-15FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (VistaPharm, LLC)
FDA approved a supplemental application for methadone hydrochloride by VistaPharm, LLC, indicating changes to the existing approval for the …
-
FDA approval · 2023-12-15FDA Approved: FENTANYL TRANSDERMAL — Supplemental Application (SpecGx LLC)
FDA approves a supplemental application for fentanyl transdermal patch manufactured by SpecGx LLC.
-
FDA approval · 2023-12-15FDA Approved: HYDROCODONE BITARTRATE AND IBUPROFEN — Supplemental Application (Aurolife Pharma, LLC)
FDA approved a supplemental application for HYDROCODONE BITARTRATE AND IBUPROFEN from Aurolife Pharma, LLC.
-
FDA approval · 2023-12-15FDA Approved: PENTAZOCINE AND NALOXONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for the pentazocine and naloxone analgesic product from Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2023-12-15FDA Approved: OXYCODONE AND ACETAMINOPHEN — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' supplemental application to market a generic oxycodone/acetaminophen product.